Capstone Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $3.61M | Sell |
7,357
-775
| -10% | -$381K | 0.1% | 237 |
|
|
2017
Q1 | $3.15M | Sell |
8,132
-165
| -2% | -$63.9K | 0.09% | 272 |
|
|
2016
Q4 | $3.05M | Sell |
8,297
-1,265
| -13% | -$464K | 0.09% | 274 |
|
|
2016
Q3 | $3.84M | Sell |
9,562
-79
| -0.8% | -$31.8K | 0.11% | 213 |
|
|
2016
Q2 | $3.37M | Buy |
9,641
+592
| +7% | +$207K | 0.1% | 234 |
|
|
2016
Q1 | $3.26M | Buy |
9,049
+372
| +4% | +$134K | 0.09% | 270 |
|
|
2015
Q4 | $4.71M | Buy |
8,677
+949
| +12% | +$515K | 0.14% | 180 |
|
|
2015
Q3 | $3.6M | Buy |
7,728
+378
| +5% | +$176K | 0.11% | 220 |
|
|
2015
Q2 | $3.75M | Sell |
7,350
-356
| -5% | -$182K | 0.11% | 237 |
|
|
2015
Q1 | $3.48M | Buy |
7,706
+136
| +2% | +$61.4K | 0.1% | 256 |
|
|
2014
Q4 | $3.11M | Buy |
7,570
+905
| +14% | +$371K | 0.09% | 277 |
|
|
2014
Q3 | $2.4M | Sell |
6,665
-58
| -0.9% | -$20.9K | 0.08% | 284 |
|
|
2014
Q2 | $1.9M | Sell |
6,723
-1,085
| -14% | -$306K | 0.06% | 363 |
|
|
2014
Q1 | $2.35M | Sell |
7,808
-913
| -10% | -$274K | 0.07% | 323 |
|
|
2013
Q4 | $2.4M | Sell |
8,721
-5,073
| -37% | -$1.4M | 0.07% | 325 |
|
|
2013
Q3 | $4.32M | Buy |
13,794
+584
| +4% | +$183K | 0.1% | 212 |
|
|
2013
Q2 | $2.97M | Buy |
+13,210
| New | +$2.97M | 0.08% | 281 |
|